Molecular Characterization of HIV Type 1 Among HIV-Infected Respondents in a Cohort Being Prepared for HIV Phase III Vaccine Clinical Trials, Western Kenya
AIDS Research and Human Retroviruses - United States
doi 10.1089/aid.2010.0061
Full Text
Open PDFAbstract
Available in full text
Date
March 1, 2011
Authors
Publisher
Mary Ann Liebert Inc